DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Expanding Medication-Assisted Therapies in Central Asia

Not Applicable

Recruiting

Conditions: Opioid Use Disorder

Interventions: Behavioral: NIATx

First Posted Date: 2022-10-13

Last Posted Date: 2024-07-26

Lead Sponsor: Yale University

Target Recruit Count: 900

Registration Number: NCT05579470

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇰🇿
Columbia University Global Health Research Center of Central Asia, Almaty, Kazakhstan
🇹🇯
Institute for International Health and Education, Dushanbe, Tajikistan

and more 1 locations

Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement (DEFINE-TAVR) Study.

Completed

Conditions: Aortic Valve Stenosis

First Posted Date: 2022-10-05

Last Posted Date: 2025-02-20

Lead Sponsor: Yale University

Target Recruit Count: 28

Registration Number: NCT05567809

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1

Not Applicable

Completed

Conditions: Alcohol Use
HIV

Interventions: Behavioral: IMB-motivational interviewing (MI) techniques (IMB-MI)

First Posted Date: 2022-09-30

Last Posted Date: 2024-08-06

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT05560932

Locations: 🇺🇸
West Haven CT Veterans Administration, West Haven, Connecticut, United States

Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

Not Applicable

Recruiting

Conditions: Tourette Syndrome in Adolescence

Interventions: Other: Neurofeedback from the SMA
Other: Neurofeedback from control region

First Posted Date: 2022-09-28

Last Posted Date: 2024-08-13

Lead Sponsor: Yale University

Target Recruit Count: 64

Registration Number: NCT05558566

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.

Not Applicable

Recruiting

Conditions: Type2Diabetes
Diabetes

Interventions: Behavioral: QBSafe

First Posted Date: 2022-09-26

Last Posted Date: 2024-04-26

Lead Sponsor: Yale University

Target Recruit Count: 164

Registration Number: NCT05553912

Locations: 🇺🇸
Fair Haven Community Health Center, New Haven, Connecticut, United States

Effects of Acute and Chronic Empagliflozin Heart Failure

Phase 1

Recruiting

Conditions: Heart Failure

Interventions: Drug: Empagliflozin 10 mg
Drug: Placebo

First Posted Date: 2022-09-26

Last Posted Date: 2024-12-18

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT05553938

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

Neuroimmune Mechanisms in Obesity

Phase 1

Withdrawn

Conditions: Obesity

Interventions: Drug: Intralipid Infusion

First Posted Date: 2022-09-23

Last Posted Date: 2023-06-18

Lead Sponsor: Yale University

Registration Number: NCT05553405

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle

Not Applicable

Recruiting

Conditions: Circadian Rhythm Sleep Disorder, Unspecified
Critical Illness
Sleep Deprivation

Interventions: Other: Chronobundle - light
Other: chronobundle - feeding
Other: chronobundle - mobility
Other: chronobundle - sleep

First Posted Date: 2022-09-22

Last Posted Date: 2024-12-11

Lead Sponsor: Yale University

Target Recruit Count: 160

Registration Number: NCT05551325

Locations: 🇺🇸
Yale New Haven Hospital Medical Intensive Care Unit (YNHH MICU) at York Street, New Haven, Connecticut, United States
🇺🇸
Yale New Haven Hospital Medical Intensive Care Unit (YNHH MICU) at St Raphael's Campus, New Haven, Connecticut, United States

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Phase 4

Recruiting

Conditions: HIV
Opioid Use Disorder
eHealth

Interventions: Behavioral: Decision Aid
Combination Product: Athena strategy

First Posted Date: 2022-09-21

Last Posted Date: 2025-05-16

Lead Sponsor: Yale University

Target Recruit Count: 250

Registration Number: NCT05547048

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
University of Alabama in Birmingham, Birmingham, Alabama, United States

Varenicline for Treatment of E-cigarette Dependence

Phase 2

Completed

Conditions: Smoking Cessation

Interventions: Drug: Varenicline Tartrate
Drug: Placebo

First Posted Date: 2022-09-15

Last Posted Date: 2024-12-02

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT05541497

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy